Healthcare -
Biotechnology - NASDAQ - US
$ 21.93
1.2 %
$ 3.16 B
Market Cap
-7.95
P/E
DNLI - OTHER CURRENT ASSETS
Other Current Assets DNLI - Denali Therapeutics Inc.
26.2 M
LAST VALUE
-7.46%
2 YEAR CAGR
26.81%
5 YEAR CAGR
0.00%
10 YEAR CAGR